Black Diamond Therapeutics (BDTX) Change in Cash: 2018-2024
Historic Change in Cash for Black Diamond Therapeutics (BDTX) over the last 7 years, with Dec 2024 value amounting to -$19.8 million.
- Black Diamond Therapeutics' Change in Cash rose 188.90% to $19.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $31.2 million, marking a year-over-year increase of 126.24%. This contributed to the annual value of -$19.8 million for FY2024, which is 191.78% down from last year.
- Per Black Diamond Therapeutics' latest filing, its Change in Cash stood at -$19.8 million for FY2024, which was down 191.78% from $21.6 million recorded in FY2023.
- Over the past 5 years, Black Diamond Therapeutics' Change in Cash peaked at $31.2 million during FY2021, and registered a low of -$118.9 million during FY2020.
- In the last 3 years, Black Diamond Therapeutics' Change in Cash had a median value of -$19.8 million in 2024 and averaged -$9.9 million.
- In the last 5 years, Black Diamond Therapeutics' Change in Cash plummeted by 215.36% in 2020 and then surged by 168.36% in 2023.
- Yearly analysis of 5 years shows Black Diamond Therapeutics' Change in Cash stood at -$118.9 million in 2020, then surged by 126.24% to $31.2 million in 2021, then tumbled by 201.11% to -$31.5 million in 2022, then skyrocketed by 168.36% to $21.6 million in 2023, then plummeted by 191.78% to -$19.8 million in 2024.